Ezra Holdings Limited (NASDAQ:EZRA – Get Free Report) was the target of a significant drop in short interest in October. As of October 30th, there was short interest totaling 7,845 shares, a drop of 82.0% from the October 15th total of 43,558 shares. Based on an average daily volume of 24,493 shares, the short-interest ratio is presently 0.3 days.
Analyst Upgrades and Downgrades
A number of research firms have commented on EZRA. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Ezra in a report on Friday, October 2nd. Wall Street Zen cut shares of Ezra from a “hold” rating to a “sell” rating in a report on Saturday, September 5th. One investment analyst has rated the stock with a Sell rating. According to MarketBeat, Ezra presently has an average rating of “Sell”.
Check Out Our Latest Analysis on Ezra
Ezra Stock Performance
NASDAQ EZRA remained flat at $2.61 during trading hours on Thursday. The stock has a fifty day moving average of $2.44 and a two-hundred day moving average of $3.89. Ezra has a 1 year low of $1.75 and a 1 year high of $33.80.
About Ezra
Ezra is a medical imaging company focused on preventive health screening. It offers whole-body MRI scans designed to help identify potential signs of cancer and other health concerns, with results reviewed by radiologists. The company also uses artificial intelligence in its imaging process, including technology intended to make scans more efficient. Ezra’s screening services have been offered in the United States and Canada.
See Also
- Five stocks we like better than Ezra
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
- Midterm Fallout, NVIDIA Turmoil, Anthropic’s IPO: Is Broadcom a Steal?
Receive News & Ratings for Ezra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ezra and related companies with MarketBeat.com's FREE daily email newsletter.
